Kurs
+35,75%
Kurs
+35,75%
Open
11,10
High
15,00
Low
10,40
Close
15,00
Kursutveckling under dagen för detta pressmeddelande
(DKK).
Likviditet
3,60 MDKK
Likviditet
3,60 MDKK
Rel. mcap
36,97%
Antal aktier
297 399
Likviditet under dagen för detta pressmeddelande
Kalender
Tid* | ||
2026-01-10 | N/A | Årsstämma |
2025-11-30 | N/A | Bokslutskommuniké 2025 |
2025-07-17 | 08:30 | Kvartalsrapport 2025-Q3 |
2025-04-17 | 08:30 | Kvartalsrapport 2025-Q2 |
2025-02-19 | 08:30 | Kvartalsrapport 2025-Q1 |
2025-02-03 | N/A | X-dag ordinarie utdelning CSMED 0.00 DKK |
2025-01-31 | N/A | Årsstämma |
2025-01-09 | - | 15-6 2025 |
2024-11-30 | - | Bokslutskommuniké 2024 |
2024-11-12 | - | Extra Bolagsstämma 2024 |
2024-08-15 | - | Kvartalsrapport 2024-Q3 |
2024-05-30 | - | Årsstämma |
2024-05-17 | - | Kvartalsrapport 2024-Q2 |
2024-03-01 | - | X-dag ordinarie utdelning CSMED 0.00 DKK |
2024-02-14 | - | Bokslutskommuniké 2023 |
2024-02-14 | - | Kvartalsrapport 2024-Q1 |
2023-12-15 | - | X-dag ordinarie utdelning CSMED 0.00 DKK |
2023-07-18 | - | Kvartalsrapport 2023-Q3 |
2023-05-17 | - | Kvartalsrapport 2023-Q2 |
2023-04-14 | - | Extra Bolagsstämma 2023 |
2023-02-17 | - | Kvartalsrapport 2023-Q1 |
2023-02-14 | - | Årsstämma |
2023-02-10 | - | X-dag ordinarie utdelning CSMED 0.00 DKK |
2022-11-18 | - | Bokslutskommuniké 2022 |
2022-08-13 | - | Kvartalsrapport 2022-Q3 |
2022-05-20 | - | Kvartalsrapport 2022-Q2 |
2022-02-18 | - | Kvartalsrapport 2022-Q1 |
2021-12-10 | - | X-dag ordinarie utdelning CSMED 0.00 DKK |
2021-12-09 | - | Årsstämma |
2021-11-18 | - | Bokslutskommuniké 2021 |
Beskrivning
Land | Danmark |
---|---|
Lista | Spotlight DK |
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
2022-08-18 08:30:00
CS MEDICA A/S ("CS MEDICA" or the "Company") announces today that the CFO of the Company, Gitte Lund Henriksen, has acquired 2 500 shares in CS MEDICA through several transactions, at an average price of 10,75, amounting to a total value of 27 250 DKK.
CFO and board member of CS MEDICA, Gitte Lund Henriksen, has purchased 2 500 shares in the open market at an average price of DKK 10,75 per share, corresponding to a total purchase of 27 250 DKK. The transaction has been disclosed in the Danish financial supervisory register. Following the transaction, Gitte Lund Henriksen owns 4 039 500 CS MEDICA shares.
For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/